Altria Group, Inc. filings document formal disclosures for a U.S. tobacco and nicotine-products operating company. Form 8-K reports cover quarterly and annual results, consolidated financial statements, internal control reporting, material governance changes and completed debt issuances. The filings identify registered securities including MO common stock and exchange-listed notes, and describe senior unsecured notes and guarantees by Philip Morris USA.
Proxy materials cover annual meeting voting matters, director elections, board practices, executive compensation and pay-versus-performance disclosures. The record also includes capital-structure and financial-reporting disclosures tied to Altria's operating subsidiaries, shareholder returns, tobacco and health litigation items, FDA-regulated smoke-free products and other matters affecting its regulated consumer-products business.
Altria Group, Inc. (MO) Vice President and Controller Katie F. Patterson had 1,268 shares withheld on October 14, 2026, to satisfy taxes on the vesting of Restricted Stock Units. The reported price was $71.56 per share, based on Altria’s closing price on October 13, 2026, the last trading day before vesting. After the withholding, she directly held 16,245 shares, including 6,172 Restricted Stock Units. A separate indirect holding of 266 shares was reported as held by her spouse.
Altria Group, Inc. (MO) entered into an extension agreement effective October 7, 2026, amending its $3.0 billion senior unsecured 5-year revolving credit agreement. JPMorgan Chase Bank, N.A. and Citibank, N.A. are the administrative agents, and the agreement includes the lenders named in it.
The amendment moves the agreement’s expiration from October 24, 2029, to October 24, 2030. The credit agreement is dated October 24, 2023, and was previously extended effective July 23, 2025.
Altria Group, Inc. (MO) director Kathryn B. McQuade purchased 1,500 shares of common stock on September 9, 2026 at $67.62 per share in a direct open-market transaction. Following this purchase, she directly holds 114,929 common shares, including 110,345 deferred shares in the Stock Compensation Plan for Non-Employee Directors.
She also holds phantom stock units and share equivalents linked 1-for-1 to the value of Altria common stock, totaling 10,601 underlying share equivalents in the Deferred Fee Plan for Non-Employee Directors. No Rule 10b5-1 trading plan is reported for these transactions.
ALTRIA GROUP, INC. (MO) reported the initial beneficial ownership of director Steven W. Presley on a Form 3. Presley is shown as directly holding 1,081 shares of Common Stock of Altria. The filing does not report any new purchase, sale, or option exercise, only the existing direct holdings.
Altria Group, Inc. (MO) reported that its Board of Directors increased the Board size from 10 to 11 members and elected Steven W. Presley as a director, effective August 27, 2026. He was also appointed to the Board’s Compensation and Talent Development, Innovation and Finance Committees as of that date.
The Board determined that Mr. Presley qualifies as an independent director under New York Stock Exchange standards and Altria’s independence standards. He will receive compensation under Altria’s existing program for non-employee directors. On August 28, 2026, Altria issued a press release announcing his election, furnished as Exhibit 99.1 under Regulation FD.
Altria Group, Inc. reported first-half 2026 results with net revenues of $11,539 million compared with $11,361 million in 2025 and net earnings of $4,481 million versus $3,455 million. Basic and diluted EPS were $2.67 versus $2.04. The effective tax rate declined to 22.6% from 28.0%, partly reflecting tax benefits from an IRS audit settlement and the absence of prior-year non-deductible e‑vapor goodwill impairments.
Operating income rose to $6,092 million; smokeable products segment OCI increased, while oral tobacco OCI decreased. Net cash from operating activities was $3,043 million. After $3,556 million of dividends and $335 million of share repurchases, cash and cash equivalents fell to $2,367 million, and total long-term debt (including current portion) was $24,577 million, with availability under a $3.0 billion revolver. The company is incurring restructuring charges for a $180 million USSTC facilities consolidation and a $175 million Optimize & Accelerate initiative, and continues to carry large equity stakes in ABI and Cronos whose fair values exceed their carrying amounts. Altria also remains obligated under state settlement agreements and involved in ongoing tobacco and e‑vapor litigation.
Altria Group, Inc. reported 2026 second‑quarter and first‑half results and narrowed full‑year earnings guidance. In Q2 2026, net revenues were $6.1 billion, up 0.1%, and revenues net of excise taxes were $5.4 billion, up 1.2%. Reported diluted EPS was $1.37, down 2.8%, while adjusted diluted EPS rose 2.8% to $1.48. For the first half, net revenues reached $11.5 billion (up 1.6%), revenues net of excise taxes were $10.1 billion (up 3.1%), reported diluted EPS was $2.67 (up 30.9%) and adjusted diluted EPS was $2.80 (up 4.9%).
Altria raised the lower end of its 2026 full‑year adjusted diluted EPS guidance to a range of $5.61 to $5.72, representing growth of 3.5% to 5.5% from a 2025 base of $5.42. Guidance reflects moderated e‑vapor growth, macroeconomic pressures on adult nicotine consumers, investments including contract manufacturing and its “Optimize & Accelerate” initiative, and the assumption that NJOY ACE does not return in 2026. Expected 2026 capital expenditures increased to $375 million to $450 million, primarily for consolidating USSTC manufacturing.
Shareholder returns remained sizable: in the first half, Altria returned nearly $3.9 billion via dividends and share repurchases, including $335 million spent to repurchase 5.3 million shares, with $665 million remaining under its $2 billion program. Q2 dividends totaled $1.8 billion. Smokeable products posted modest revenue and adjusted OCI growth amid declining cigarette volumes and rising discount mix, while oral tobacco saw lower revenues and OCI as traditional moist snuff volumes and retail share declined, partly offset by growth in on! nicotine pouches and overall oral industry volume.
Altria Group director Debra J. Kelly Ennis sold shares in a routine open-market transaction. On May 26, 2026, she sold 5,790 shares of Altria common stock at a weighted average price of $72.2483 per share, in multiple trades between $72.24 and $72.26. After these sales, she directly owned 73,809 Altria shares. The filing also notes deferred stock held in the Stock Compensation Plan for Non-Employee Directors.
ALTRIA GROUP, INC. director Ellen R. Strahlman reported an open-market sale of 2,000 shares of common stock on May 26, 2026. The shares were sold at a weighted average price of $72.559 per share, in multiple trades ranging from $72.50 to $72.61.
Following this transaction, Strahlman directly holds 25,102 shares of Altria common stock and also has deferred stock credited under the Stock Compensation Plan for Non-Employee Directors.
Altria Group, Inc. filed Amendment No. 1 to its annual report to add the consolidated financial statements of its foreign equity investee, Anheuser-Busch InBev SA/NV (ABI), as required by Rule 3-09 of Regulation S-X. These ABI statements were audited under Public Company Accounting Oversight Board standards.
The amendment does not change Altria’s own consolidated financial position, results of operations, cash flows, or other disclosures. As of June 30, 2025, Altria’s common stock held by non-affiliates had an aggregate market value of approximately $98 billion, and 1,671,898,087 common shares were outstanding at February 13, 2026.